Robert P. Baughman

Active 1984–2025

Also published as
Robert P Baughman
177
Papers
31,917
Citations
99
h-index
173
i10-index

Citations

Citations per year for Robert P. Baughman1981: 1 citations1982: 4 citations1983: 10 citations1984: 9 citations1985: 7 citations1986: 5 citations1987: 10 citations1988: 22 citations1989: 23 citations1990: 26 citations1991: 26 citations1992: 31 citations1993: 47 citations1994: 49 citations1995: 45 citations1996: 42 citations1997: 68 citations1998: 64 citations1999: 95 citations2000: 112 citations2001: 117 citations2002: 131 citations2003: 209 citations2004: 167 citations2005: 166 citations2006: 154 citations2007: 187 citations2008: 225 citations2009: 114 citations2010: 148 citations2011: 206 citations2012: 199 citations2013: 205 citations2014: 174 citations2015: 252 citations2016: 147 citations2017: 211 citations2018: 169 citations2019: 640 citations2020: 861 citations2021: 737 citations2022: 580 citations2023: 371 citations2024: 660 citations2025: 298 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,053 citing papers, 31.4% of this breakdownUnited Kingdom: 497 citing papers, 7.6% of this breakdownGermany: 374 citing papers, 5.7% of this breakdownFrance: 324 citing papers, 5% of this breakdownItaly: 310 citing papers, 4.7% of this breakdownNetherlands: 306 citing papers, 4.7% of this breakdownChina: 295 citing papers, 4.5% of this breakdownCanada: 278 citing papers, 4.2% of this breakdownJapan: 253 citing papers, 3.9% of this breakdownSpain: 151 citing papers, 2.3% of this breakdownAustralia: 144 citing papers, 2.2% of this breakdownBelgium: 116 citing papers, 1.8% of this breakdown
0%31.4%Other 22%

Fields

  • Medicine80.7%
  • Biochemistry, Genetics and Molecular Biology7.2%
  • Neuroscience4.8%
  • Immunology and Microbiology4.6%
  • Health Professions0.5%
  • Engineering0.4%
  • Other1.8%

Topics

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis12.1%
  • Sarcoidosis and Beryllium Toxicity Research11%
  • Sepsis Diagnosis and Treatment2.3%
  • Respiratory Support and Mechanisms2.2%
  • Neonatal Respiratory Health Research2%
  • Immune Response and Inflammation1.8%
  • Other68.6%

Coauthors

All papers

Open in search
  1. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 cited by 1,029

  2. ERS clinical practice guidelines on treatment of sarcoidosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2021 cited by 584

  3. PD-1 up-regulation on CD4 + T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2018 cited by 366

  4. An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease

    Authors: , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2012 cited by 1,134

  5. Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2001 cited by 1,804

  6. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - 2014 cited by 504

  7. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Critical Care Medicine 1997 cited by 863

  8. Challenges in Cardiac and Pulmonary Sarcoidosis

    Authors: , , , , , , , , - Journal of the American College of Cardiology 2020 cited by 206

  9. A Case Control Etiologic Study of Sarcoidosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2004 cited by 799

  10. Sarcoidosis in America. Analysis Based on Health Care Use

    Authors: , , , , , , , - Annals of the American Thoracic Society 2016 cited by 419

  11. Definition and Consensus Diagnostic Criteria for Neurosarcoidosis

    Authors: , , , , , , , , , , , , , - JAMA Neurology 2018 cited by 381

  12. Racial Difference in Sarcoidosis Mortality in the United States

    Authors: , , , , - CHEST Journal 2014 cited by 250

  13. Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement

    Authors: , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2006 cited by 709

  14. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 1998 cited by 503

  15. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Review 2020 cited by 158

  16. Efzofitimod for the Treatment of Pulmonary Sarcoidosis

    Authors: , , , , , , , , , , , , , - CHEST Journal 2022 cited by 51

  17. Predictors of Mortality in Pulmonary Sarcoidosis

    Authors: , , - CHEST Journal 2017 cited by 242

  18. High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antje Prasse, Antonietta Mazzei, António Morais, Ashu Seith Bhalla, Belén del Río, Bhavin Jankharia, Brett M. Elicker, Carlos A.C. Pereira, Catherine Biegelman-Aubry, Charles S. White, Claudia Ravaglia, Connie C. W. Hsia, Cornelia Schaefer‐Prokop, David Launay, Deepak Talwar, Diego Castillo, Divya Patel, Dominique Israël‐Biet, Dominique Valeyre, E. James Britt, Elena Bargagli, Elisabeth Bendstrup, Elliott D. Crouser, Esther J. Nossent, Eugeny Shmelev, Eva Carmona Porquera, Francesco Bonella, Fleur Cohen‐Aubart, Florence Jeny, Giovanni Ferrara, Gong Yong Jin, Hasti Robbie, Helmut Prosch, Hiromitsu Sumikawa, Ho Ling-Pei, Ho Yun Lee, Irina Strâmbu, Ivette Buendía-Roldán, Jan Grutters, Jay H. Ryu, Jeff Swigris, Jelle Miedema, Jin Mo Goo, Joseph Barnett, Johny Verschakelen, Jonathan Goldin, Joon Beom Seo, Juan Ignacio Enghelmayer, Juan Mañá, Juergen Behr, Karen Patterson, Κατερίνα Αντωνίου, Kevin M. Brown, Kiminori Fujimoto, Laurent Savale, Lisa A. Maier, Luca Richeldi, Manuel L. Ribeiro Neto, Marc Humbert, Marc A. Judson, Marcel Veltkamp, Margaret Wilsher, María Molina‐Molina, María Otaola, Marie‐Pierre Revel, Mario Silva, Marjolein Drent, Mark L. Schiebler, Marlies Wijsenbeek-Lourens, Martina Bonifazi and 50 more - The Lancet Respiratory Medicine 2023 cited by 67

  19. Pulmonary sarcoidosis

    Authors: , , , , , - The Lancet Respiratory Medicine 2018 cited by 943

  20. Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry

    Authors: , , , , , , , , , , , , , , , , , - European Respiratory Journal 2020 cited by 94

  21. Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis

    Authors: , , , , , , , , , , , , , , , , - European Respiratory Journal 2014 cited by 212

  22. Chronic pulmonary aspergillosis complicating sarcoidosis

    Authors: , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 95

  23. Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis

    Authors: , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2019 cited by 92

  24. WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension

    Authors: , , , , , , , , , , , , , , , - European Respiratory Review 2022 cited by 62